ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live Attenuated Herpes Zoster Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-16C14184
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Live Attenuated Herpes Zoster Vaccine Market Research Report 2023
BUY CHAPTERS

Global Live Attenuated Herpes Zoster Vaccine Market Research Report 2025

Code: QYRE-Auto-16C14184
Report
May 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
SK Bioscience
GlaxoSmithKline(GSK )
Beike Bio

Live Attenuated Herpes Zoster Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Live Attenuated Herpes Zoster Vaccine Market

Live Attenuated Herpes Zoster Vaccine Market

The global market for Live Attenuated Herpes Zoster Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Live Attenuated Herpes Zoster Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Herpes Zoster Vaccine.
The Live Attenuated Herpes Zoster Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live Attenuated Herpes Zoster Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Attenuated Herpes Zoster Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Live Attenuated Herpes Zoster Vaccine Market Report

Report Metric Details
Report Name Live Attenuated Herpes Zoster Vaccine Market
CAGR 5%
Segment by Type
  • 40-50 Years Old
  • 50-60 Years Old
  • 60-70 Years Old
  • >70 Years Old
Segment by Application
  • Hospital
  • Clinic
  • Epidemic Prevention Center
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck & Co., SK Bioscience, GlaxoSmithKline (GSK), Beike Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Live Attenuated Herpes Zoster Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Live Attenuated Herpes Zoster Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Live Attenuated Herpes Zoster Vaccine Market report?

Ans: The main players in the Live Attenuated Herpes Zoster Vaccine Market are Merck & Co., SK Bioscience, GlaxoSmithKline (GSK), Beike Bio

What are the Application segmentation covered in the Live Attenuated Herpes Zoster Vaccine Market report?

Ans: The Applications covered in the Live Attenuated Herpes Zoster Vaccine Market report are Hospital, Clinic, Epidemic Prevention Center, Others

What are the Type segmentation covered in the Live Attenuated Herpes Zoster Vaccine Market report?

Ans: The Types covered in the Live Attenuated Herpes Zoster Vaccine Market report are 40-50 Years Old, 50-60 Years Old, 60-70 Years Old, >70 Years Old

Recommended Reports

Vaccine Markets

Herpes & Treatment

Vaccine Delivery

1 Live Attenuated Herpes Zoster Vaccine Market Overview
1.1 Product Definition
1.2 Live Attenuated Herpes Zoster Vaccine by Type
1.2.1 Global Live Attenuated Herpes Zoster Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 40-50 Years Old
1.2.3 50-60 Years Old
1.2.4 60-70 Years Old
1.2.5 >70 Years Old
1.3 Live Attenuated Herpes Zoster Vaccine by Application
1.3.1 Global Live Attenuated Herpes Zoster Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Epidemic Prevention Center
1.3.5 Others
1.4 Global Live Attenuated Herpes Zoster Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Herpes Zoster Vaccine Revenue 2020-2031
1.4.2 Global Live Attenuated Herpes Zoster Vaccine Sales 2020-2031
1.4.3 Global Live Attenuated Herpes Zoster Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Live Attenuated Herpes Zoster Vaccine Market Competition by Manufacturers
2.1 Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Live Attenuated Herpes Zoster Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Live Attenuated Herpes Zoster Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Attenuated Herpes Zoster Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Attenuated Herpes Zoster Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live Attenuated Herpes Zoster Vaccine, Date of Enter into This Industry
2.8 Global Live Attenuated Herpes Zoster Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Attenuated Herpes Zoster Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live Attenuated Herpes Zoster Vaccine Players Market Share by Revenue
2.8.3 Global Live Attenuated Herpes Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Attenuated Herpes Zoster Vaccine Market Scenario by Region
3.1 Global Live Attenuated Herpes Zoster Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Live Attenuated Herpes Zoster Vaccine Sales by Region: 2020-2031
3.2.1 Global Live Attenuated Herpes Zoster Vaccine Sales by Region: 2020-2025
3.2.2 Global Live Attenuated Herpes Zoster Vaccine Sales by Region: 2026-2031
3.3 Global Live Attenuated Herpes Zoster Vaccine Revenue by Region: 2020-2031
3.3.1 Global Live Attenuated Herpes Zoster Vaccine Revenue by Region: 2020-2025
3.3.2 Global Live Attenuated Herpes Zoster Vaccine Revenue by Region: 2026-2031
3.4 North America Live Attenuated Herpes Zoster Vaccine Market Facts & Figures by Country
3.4.1 North America Live Attenuated Herpes Zoster Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2031)
3.4.3 North America Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Attenuated Herpes Zoster Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Attenuated Herpes Zoster Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2031)
3.5.3 Europe Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Attenuated Herpes Zoster Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Attenuated Herpes Zoster Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Live Attenuated Herpes Zoster Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Live Attenuated Herpes Zoster Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live Attenuated Herpes Zoster Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Attenuated Herpes Zoster Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live Attenuated Herpes Zoster Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Attenuated Herpes Zoster Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Attenuated Herpes Zoster Vaccine Sales by Type (2020-2031)
4.1.1 Global Live Attenuated Herpes Zoster Vaccine Sales by Type (2020-2025)
4.1.2 Global Live Attenuated Herpes Zoster Vaccine Sales by Type (2026-2031)
4.1.3 Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Live Attenuated Herpes Zoster Vaccine Revenue by Type (2020-2031)
4.2.1 Global Live Attenuated Herpes Zoster Vaccine Revenue by Type (2020-2025)
4.2.2 Global Live Attenuated Herpes Zoster Vaccine Revenue by Type (2026-2031)
4.2.3 Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Live Attenuated Herpes Zoster Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Live Attenuated Herpes Zoster Vaccine Sales by Application (2020-2031)
5.1.1 Global Live Attenuated Herpes Zoster Vaccine Sales by Application (2020-2025)
5.1.2 Global Live Attenuated Herpes Zoster Vaccine Sales by Application (2026-2031)
5.1.3 Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Live Attenuated Herpes Zoster Vaccine Revenue by Application (2020-2031)
5.2.1 Global Live Attenuated Herpes Zoster Vaccine Revenue by Application (2020-2025)
5.2.2 Global Live Attenuated Herpes Zoster Vaccine Revenue by Application (2026-2031)
5.2.3 Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Live Attenuated Herpes Zoster Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Company Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Live Attenuated Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck & Co. Live Attenuated Herpes Zoster Vaccine Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 SK Bioscience
6.2.1 SK Bioscience Company Information
6.2.2 SK Bioscience Description and Business Overview
6.2.3 SK Bioscience Live Attenuated Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 SK Bioscience Live Attenuated Herpes Zoster Vaccine Product Portfolio
6.2.5 SK Bioscience Recent Developments/Updates
6.3 GlaxoSmithKline (GSK)
6.3.1 GlaxoSmithKline (GSK) Company Information
6.3.2 GlaxoSmithKline (GSK) Description and Business Overview
6.3.3 GlaxoSmithKline (GSK) Live Attenuated Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline (GSK) Live Attenuated Herpes Zoster Vaccine Product Portfolio
6.3.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.4 Beike Bio
6.4.1 Beike Bio Company Information
6.4.2 Beike Bio Description and Business Overview
6.4.3 Beike Bio Live Attenuated Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beike Bio Live Attenuated Herpes Zoster Vaccine Product Portfolio
6.4.5 Beike Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Attenuated Herpes Zoster Vaccine Industry Chain Analysis
7.2 Live Attenuated Herpes Zoster Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Attenuated Herpes Zoster Vaccine Production Mode & Process Analysis
7.4 Live Attenuated Herpes Zoster Vaccine Sales and Marketing
7.4.1 Live Attenuated Herpes Zoster Vaccine Sales Channels
7.4.2 Live Attenuated Herpes Zoster Vaccine Distributors
7.5 Live Attenuated Herpes Zoster Vaccine Customer Analysis
8 Live Attenuated Herpes Zoster Vaccine Market Dynamics
8.1 Live Attenuated Herpes Zoster Vaccine Industry Trends
8.2 Live Attenuated Herpes Zoster Vaccine Market Drivers
8.3 Live Attenuated Herpes Zoster Vaccine Market Challenges
8.4 Live Attenuated Herpes Zoster Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
SK Bioscience
GlaxoSmithKline(GSK )
Beike Bio
List of Tables
 Table 1. Global Live Attenuated Herpes Zoster Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Live Attenuated Herpes Zoster Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Live Attenuated Herpes Zoster Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Live Attenuated Herpes Zoster Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Live Attenuated Herpes Zoster Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Live Attenuated Herpes Zoster Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Live Attenuated Herpes Zoster Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Live Attenuated Herpes Zoster Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Live Attenuated Herpes Zoster Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Live Attenuated Herpes Zoster Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Live Attenuated Herpes Zoster Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Live Attenuated Herpes Zoster Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Herpes Zoster Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Live Attenuated Herpes Zoster Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Live Attenuated Herpes Zoster Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Live Attenuated Herpes Zoster Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Live Attenuated Herpes Zoster Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Live Attenuated Herpes Zoster Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Live Attenuated Herpes Zoster Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Live Attenuated Herpes Zoster Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Live Attenuated Herpes Zoster Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Live Attenuated Herpes Zoster Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Live Attenuated Herpes Zoster Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Live Attenuated Herpes Zoster Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Live Attenuated Herpes Zoster Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Live Attenuated Herpes Zoster Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Live Attenuated Herpes Zoster Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Live Attenuated Herpes Zoster Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Live Attenuated Herpes Zoster Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Live Attenuated Herpes Zoster Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Live Attenuated Herpes Zoster Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Live Attenuated Herpes Zoster Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Live Attenuated Herpes Zoster Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Live Attenuated Herpes Zoster Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Live Attenuated Herpes Zoster Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Live Attenuated Herpes Zoster Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Live Attenuated Herpes Zoster Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Live Attenuated Herpes Zoster Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Live Attenuated Herpes Zoster Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Live Attenuated Herpes Zoster Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Live Attenuated Herpes Zoster Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Live Attenuated Herpes Zoster Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Live Attenuated Herpes Zoster Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Live Attenuated Herpes Zoster Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Live Attenuated Herpes Zoster Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Live Attenuated Herpes Zoster Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Live Attenuated Herpes Zoster Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Live Attenuated Herpes Zoster Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Live Attenuated Herpes Zoster Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Live Attenuated Herpes Zoster Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck & Co. Company Information
 Table 71. Merck & Co. Description and Business Overview
 Table 72. Merck & Co. Live Attenuated Herpes Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck & Co. Live Attenuated Herpes Zoster Vaccine Product
 Table 74. Merck & Co. Recent Developments/Updates
 Table 75. SK Bioscience Company Information
 Table 76. SK Bioscience Description and Business Overview
 Table 77. SK Bioscience Live Attenuated Herpes Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. SK Bioscience Live Attenuated Herpes Zoster Vaccine Product
 Table 79. SK Bioscience Recent Developments/Updates
 Table 80. GlaxoSmithKline (GSK) Company Information
 Table 81. GlaxoSmithKline (GSK) Description and Business Overview
 Table 82. GlaxoSmithKline (GSK) Live Attenuated Herpes Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline (GSK) Live Attenuated Herpes Zoster Vaccine Product
 Table 84. GlaxoSmithKline (GSK) Recent Developments/Updates
 Table 85. Beike Bio Company Information
 Table 86. Beike Bio Description and Business Overview
 Table 87. Beike Bio Live Attenuated Herpes Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Beike Bio Live Attenuated Herpes Zoster Vaccine Product
 Table 89. Beike Bio Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Live Attenuated Herpes Zoster Vaccine Distributors List
 Table 93. Live Attenuated Herpes Zoster Vaccine Customers List
 Table 94. Live Attenuated Herpes Zoster Vaccine Market Trends
 Table 95. Live Attenuated Herpes Zoster Vaccine Market Drivers
 Table 96. Live Attenuated Herpes Zoster Vaccine Market Challenges
 Table 97. Live Attenuated Herpes Zoster Vaccine Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Live Attenuated Herpes Zoster Vaccine
 Figure 2. Global Live Attenuated Herpes Zoster Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Live Attenuated Herpes Zoster Vaccine Market Share by Type: 2024 & 2031
 Figure 4. 40-50 Years Old Product Picture
 Figure 5. 50-60 Years Old Product Picture
 Figure 6. 60-70 Years Old Product Picture
 Figure 7. >70 Years Old Product Picture
 Figure 8. Global Live Attenuated Herpes Zoster Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Live Attenuated Herpes Zoster Vaccine Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Epidemic Prevention Center
 Figure 13. Others
 Figure 14. Global Live Attenuated Herpes Zoster Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Live Attenuated Herpes Zoster Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Live Attenuated Herpes Zoster Vaccine Sales (2020-2031) & (K Units)
 Figure 17. Global Live Attenuated Herpes Zoster Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 18. Live Attenuated Herpes Zoster Vaccine Report Years Considered
 Figure 19. Live Attenuated Herpes Zoster Vaccine Sales Share by Manufacturers in 2024
 Figure 20. Global Live Attenuated Herpes Zoster Vaccine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Live Attenuated Herpes Zoster Vaccine Players: Market Share by Revenue in Live Attenuated Herpes Zoster Vaccine in 2024
 Figure 22. Live Attenuated Herpes Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Live Attenuated Herpes Zoster Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Live Attenuated Herpes Zoster Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. North America Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. United States Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Live Attenuated Herpes Zoster Vaccine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Live Attenuated Herpes Zoster Vaccine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Region (2020-2031)
 Figure 37. China Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Live Attenuated Herpes Zoster Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Live Attenuated Herpes Zoster Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Live Attenuated Herpes Zoster Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Live Attenuated Herpes Zoster Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Live Attenuated Herpes Zoster Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Live Attenuated Herpes Zoster Vaccine by Type (2020-2031)
 Figure 56. Global Live Attenuated Herpes Zoster Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Live Attenuated Herpes Zoster Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Live Attenuated Herpes Zoster Vaccine by Application (2020-2031)
 Figure 59. Global Live Attenuated Herpes Zoster Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Live Attenuated Herpes Zoster Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Zoster Vaccine Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025
Global Recombinant Zoster Vaccine Market Research Report 2025
Global Herpes Zoste Drug Market Research Report 2025
Global Live Attenuated Varicella Vaccine Market Research Report 2025
Global Live Attenuated Measles Vaccine Market Research Report 2025
Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025
Global Attenuated Vaccine Market Research Report 2025
Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attenuated Vaccine for Human Rabies Market Research Report 2025
Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herpes Infection Treatment Market Research Report 2025
Genital Herpes Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chickenpox Varicella Vaccine Market
Global Viral Vaccines Market Research Report 2025
Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multivalent Vaccines Market Research Report 2025
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions